SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-17-013934
Filing Date
2017-02-23
Accepted
2017-02-23 17:35:44
Documents
2
Period of Report
2016-06-15

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3336
2 POA DOCUMENT poa.txt EX-24.4A_705227 3552
  Complete submission text file 0001209191-17-013934.txt   8380
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220 EMERYVILLE CA 94608
Business Address
Went Gregory T (Reporting) CIK: 0001604541 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-36399 | Film No.: 17633867